Delta Radiomic Features Predict Resection Margin Status and Overall Survival in Neoadjuvant-Treated Pancreatic Cancer Patients

CONCLUSIONS: Our externally validated, predictive/prognostic delta-radiomics models, which incorporate clinical variables, show promise in predicting the risk of predicting RMS in NAT-treated PDAC patients and their OS or DFS.PMID:38151623 | DOI:10.1245/s10434-023-14805-5

Source: Ann Oncol - December 27, 2023 Category: Cancer & Oncology Authors: Kai Wang John D Karalis Ahmed Elamir Alessandro Bifolco Megan Wachsmann Giovanni Capretti Paola Spaggiari Sebastian Enrico Kishore Balasubramanian Nafeesah Fatimah Giada Pontecorvi Martina Nebbia Adam Yopp Ravi Kaza Ivan Pedrosa Herbert Zeh Patricio Polan Source Type: research